Diagnostyka Q3 profit soars on higher test volumes and prices
20/11/2025 16:45
GDANSK, Nov 20 (Reuters) - Poland's Diagnostyka reported a 52.5% year-on-year jump in third-quarter net profit to 78.1 million zlotys ($20.1 million), as the medical diagnostics group benefited from higher test volumes and prices. The company's growth was driven by stable demand, acquisitions, and a more profitable mix of services. WHY IT'S IMPORTANT Diagnostyka is one of Poland's leading providers of medical diagnostic services, spanning both laboratory and imaging tests. CONTEXT During the quarter, Diagnostyka finalized five acquisitions. The company is continuing its strategy of expanding through acquisitions, particularly in the field of diagnostic imaging. BY THE NUMBERS Third-quarter revenue rose 26.6% year-on-year to 615.1 million zlotys. Recurring EBITDA, a measure of core profitability, increased by 22.3% to 152.2 million zlotys. The volume of tests performed grew by 10.9% to 43.0 million, while the average price per test increased by 14.5% from a year earlier. ($1 = 3.6405 zlotys) (Reporting by Marta Maciag; Editing by Matt Scuffham) ((Marta.Maciag@thomsonreuters.com))